Transcutaneous electrical nerve stimulation for mental disease

未提供0 个研究点目标入组 120 人开始时间: 待定

适应症

试验速览

暂无简介。

•Patients with uveitis who are receiving outpatient care or are hospitalized at Hokkaido University Hospital between the date of study approval and March 31, 2028, and who meet all of the following inclusion criteria:
•Aged from 18 years to 65 years at the time consent is obtained
•Patients who, after receiving a sufficient explanation of the study, are able to actively understand the written informed consent document on their own and who provide written consent of their own free will

•Patients who meet any one of the following criteria will be excluded:
•Patients with a history of progressive cerebral lesions
•Patients undergoing concomitant vagus nerve stimulation therapy
•Patients with a history of severe cardiovascular disease
•Patients with a history of hypersensitivity to glycerin
•Patients with an active malignant tumor
•Patients who are pregnant or breastfeeding
•Patients with a history of skin reactions caused by metals or similar materials
•Patients using a cardiac pacemaker or an implantable cardioverter defibrillator
•Patients otherwise judged by the principal investigator or a sub-investigator to be unsuitable as study participants

发起方

未提供